Ticker Details
Charles River Laboratories International, Inc. Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.
IPO Date:	June 23, 2000
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$8.66B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.41 | 1.21%
Avg Daily Range (30 D):	$3.52 | 2.11%
Avg Daily Range (90 D):	$3.69 | 2.04%

Institutional Daily Volume
Avg Daily Volume:	.53M
Avg Daily Volume (30 D):	.66M
Avg Daily Volume (90 D):	.68M

Trade Size
Avg Trade Size (Sh.):	86
Avg Trade Size (Sh.) (30 D):	38
Avg Trade Size (Sh.) (90 D):	38

Institutional Trades
Total Institutional Trades:	13,574
Avg Institutional Trade:	$4.36M
Avg Institutional Trade (30 D):	$15.73M
Avg Institutional Trade (90 D):	$12.37M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$8.94M
Avg Closing Trade (30 D):	$28.74M
Avg Closing Trade (90 D):	$25.01M
Avg Closing Volume:	57.34K

News

Mar 10, 2026 @ 6:00 PM [Latest] Global Pharmaceutical Microbiology QC Tes... Source: Custom Market Insights

Feb 25, 2026 @ 2:06 PM Charles River Labs Breaks The Mold, Announces Bold... Source: Vandana Singh

Feb 3, 2026 @ 6:00 PM [Latest] Global Adeno Associated Virus Vector Manu... Source: Custom Market Insights

Nov 28, 2025 @ 3:00 PM Lead Optimization Services in Drug Discovery Marke... Source: Towards Healthcare

Nov 28, 2025 @ 2:00 PM Innovative Drug CRO Market to Soar USD 96.06 Billi... Source: Towards Healthcare

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-2.91	$-5.57	$-2.91
Diluted EPS	$-2.91	$-5.56	$-2.91
Revenue	$4.02B	$994.23M	$4.02B
Gross Profit
Net Income / Loss	$-142.16M	$-276.29M	$-142.16M
Operating Income / Loss	$25.16M	$-283.44M	$25.16M
Cost of Revenue
Net Cash Flow	$10.43M	$6.78M	$10.43M
PE Ratio